Circulating Levels and Dietary Intake of the Advanced Glycation End-product Marker Carboxymethyl Lysine in Chronic Kidney Disease Patients on Conservative Predialysis Therapy: A Pilot Study

Marta Piroddi, Ingrid Palazzetti, Giuseppe Quintaliani, Francesca Pilolli, Massimiliano Montaldi, Viola Valentina, Carmelo Libetta, Francesco Galli

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Objective: Advanced glycation end-products (AGEs) are proposed to influence inflammatory pathways and cardiovascular risk in chronic kidney disease (CKD). Dietary AGEs are believed to sustain circulating levels and toxicity in this condition. Design and Patients: We investigated this aspect in a cross-sectional pilot study measuring levels of the AGE marker carboxymethyl lysine (CML) and fluorescent AGEs in the blood of pre-dialysis patients with CKD and hemodialysis (HD) patients (n = 10 each), and in a group of matched healthy controls (Ctr). Methods: Plasma CML was measured by immuno-dot blot and fluorescent AGEs were determined by high-performace liquid chromatography (HPLC) analysis measuring the fluorescence of the cross-link pentosidine. The dietary intake of CML was assessed by dietary recall to trace total AGE intake in patients with CKD and the Ctr group. All the subjects included in the study were assessed for dietary intake while maintaining their usual diet. Main exclusion criteria for patients with CKD and HD were severe protein-caloric malnutrition and inflammation (measured by high sensitivity C-reactive protein and interleukin-6 levels). Results: Plasma CML, as well as free and protein-bound fluorescent AGEs, significantly increased in CKD and even more in HD patients than that of the Ctr group. In patients with CKD, the average dietary intake of CML was less than half than that of the Ctr group (6 vs. 13 MU/day) and the lowered protein intake adopted spontaneously by these patients appear to explain this finding. Conclusions: The results show that the intake of CML does not affect circulating levels of this as well as of other AGEs, in well nourished predialysis CKD patients.

Original languageEnglish
Pages (from-to)329-339
Number of pages11
JournalJournal of Renal Nutrition
Volume21
Issue number4
DOIs
Publication statusPublished - Jul 2011

Fingerprint

Advanced Glycosylation End Products
Chronic Renal Insufficiency
Renal Dialysis
Control Groups
N(6)-carboxymethyllysine
Conservative Treatment
Proteins
Malnutrition
Liquid Chromatography
C-Reactive Protein
Dialysis
Interleukin-6
Research Design
Cross-Sectional Studies
Fluorescence
Diet
Inflammation

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Nephrology

Cite this

Circulating Levels and Dietary Intake of the Advanced Glycation End-product Marker Carboxymethyl Lysine in Chronic Kidney Disease Patients on Conservative Predialysis Therapy : A Pilot Study. / Piroddi, Marta; Palazzetti, Ingrid; Quintaliani, Giuseppe; Pilolli, Francesca; Montaldi, Massimiliano; Valentina, Viola; Libetta, Carmelo; Galli, Francesco.

In: Journal of Renal Nutrition, Vol. 21, No. 4, 07.2011, p. 329-339.

Research output: Contribution to journalArticle

Piroddi, Marta ; Palazzetti, Ingrid ; Quintaliani, Giuseppe ; Pilolli, Francesca ; Montaldi, Massimiliano ; Valentina, Viola ; Libetta, Carmelo ; Galli, Francesco. / Circulating Levels and Dietary Intake of the Advanced Glycation End-product Marker Carboxymethyl Lysine in Chronic Kidney Disease Patients on Conservative Predialysis Therapy : A Pilot Study. In: Journal of Renal Nutrition. 2011 ; Vol. 21, No. 4. pp. 329-339.
@article{11b6dae602ba4a25b8fbbeab83f70540,
title = "Circulating Levels and Dietary Intake of the Advanced Glycation End-product Marker Carboxymethyl Lysine in Chronic Kidney Disease Patients on Conservative Predialysis Therapy: A Pilot Study",
abstract = "Objective: Advanced glycation end-products (AGEs) are proposed to influence inflammatory pathways and cardiovascular risk in chronic kidney disease (CKD). Dietary AGEs are believed to sustain circulating levels and toxicity in this condition. Design and Patients: We investigated this aspect in a cross-sectional pilot study measuring levels of the AGE marker carboxymethyl lysine (CML) and fluorescent AGEs in the blood of pre-dialysis patients with CKD and hemodialysis (HD) patients (n = 10 each), and in a group of matched healthy controls (Ctr). Methods: Plasma CML was measured by immuno-dot blot and fluorescent AGEs were determined by high-performace liquid chromatography (HPLC) analysis measuring the fluorescence of the cross-link pentosidine. The dietary intake of CML was assessed by dietary recall to trace total AGE intake in patients with CKD and the Ctr group. All the subjects included in the study were assessed for dietary intake while maintaining their usual diet. Main exclusion criteria for patients with CKD and HD were severe protein-caloric malnutrition and inflammation (measured by high sensitivity C-reactive protein and interleukin-6 levels). Results: Plasma CML, as well as free and protein-bound fluorescent AGEs, significantly increased in CKD and even more in HD patients than that of the Ctr group. In patients with CKD, the average dietary intake of CML was less than half than that of the Ctr group (6 vs. 13 MU/day) and the lowered protein intake adopted spontaneously by these patients appear to explain this finding. Conclusions: The results show that the intake of CML does not affect circulating levels of this as well as of other AGEs, in well nourished predialysis CKD patients.",
author = "Marta Piroddi and Ingrid Palazzetti and Giuseppe Quintaliani and Francesca Pilolli and Massimiliano Montaldi and Viola Valentina and Carmelo Libetta and Francesco Galli",
year = "2011",
month = "7",
doi = "10.1053/j.jrn.2010.06.024",
language = "English",
volume = "21",
pages = "329--339",
journal = "Journal of Renal Nutrition",
issn = "1051-2276",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Circulating Levels and Dietary Intake of the Advanced Glycation End-product Marker Carboxymethyl Lysine in Chronic Kidney Disease Patients on Conservative Predialysis Therapy

T2 - A Pilot Study

AU - Piroddi, Marta

AU - Palazzetti, Ingrid

AU - Quintaliani, Giuseppe

AU - Pilolli, Francesca

AU - Montaldi, Massimiliano

AU - Valentina, Viola

AU - Libetta, Carmelo

AU - Galli, Francesco

PY - 2011/7

Y1 - 2011/7

N2 - Objective: Advanced glycation end-products (AGEs) are proposed to influence inflammatory pathways and cardiovascular risk in chronic kidney disease (CKD). Dietary AGEs are believed to sustain circulating levels and toxicity in this condition. Design and Patients: We investigated this aspect in a cross-sectional pilot study measuring levels of the AGE marker carboxymethyl lysine (CML) and fluorescent AGEs in the blood of pre-dialysis patients with CKD and hemodialysis (HD) patients (n = 10 each), and in a group of matched healthy controls (Ctr). Methods: Plasma CML was measured by immuno-dot blot and fluorescent AGEs were determined by high-performace liquid chromatography (HPLC) analysis measuring the fluorescence of the cross-link pentosidine. The dietary intake of CML was assessed by dietary recall to trace total AGE intake in patients with CKD and the Ctr group. All the subjects included in the study were assessed for dietary intake while maintaining their usual diet. Main exclusion criteria for patients with CKD and HD were severe protein-caloric malnutrition and inflammation (measured by high sensitivity C-reactive protein and interleukin-6 levels). Results: Plasma CML, as well as free and protein-bound fluorescent AGEs, significantly increased in CKD and even more in HD patients than that of the Ctr group. In patients with CKD, the average dietary intake of CML was less than half than that of the Ctr group (6 vs. 13 MU/day) and the lowered protein intake adopted spontaneously by these patients appear to explain this finding. Conclusions: The results show that the intake of CML does not affect circulating levels of this as well as of other AGEs, in well nourished predialysis CKD patients.

AB - Objective: Advanced glycation end-products (AGEs) are proposed to influence inflammatory pathways and cardiovascular risk in chronic kidney disease (CKD). Dietary AGEs are believed to sustain circulating levels and toxicity in this condition. Design and Patients: We investigated this aspect in a cross-sectional pilot study measuring levels of the AGE marker carboxymethyl lysine (CML) and fluorescent AGEs in the blood of pre-dialysis patients with CKD and hemodialysis (HD) patients (n = 10 each), and in a group of matched healthy controls (Ctr). Methods: Plasma CML was measured by immuno-dot blot and fluorescent AGEs were determined by high-performace liquid chromatography (HPLC) analysis measuring the fluorescence of the cross-link pentosidine. The dietary intake of CML was assessed by dietary recall to trace total AGE intake in patients with CKD and the Ctr group. All the subjects included in the study were assessed for dietary intake while maintaining their usual diet. Main exclusion criteria for patients with CKD and HD were severe protein-caloric malnutrition and inflammation (measured by high sensitivity C-reactive protein and interleukin-6 levels). Results: Plasma CML, as well as free and protein-bound fluorescent AGEs, significantly increased in CKD and even more in HD patients than that of the Ctr group. In patients with CKD, the average dietary intake of CML was less than half than that of the Ctr group (6 vs. 13 MU/day) and the lowered protein intake adopted spontaneously by these patients appear to explain this finding. Conclusions: The results show that the intake of CML does not affect circulating levels of this as well as of other AGEs, in well nourished predialysis CKD patients.

UR - http://www.scopus.com/inward/record.url?scp=79959238921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959238921&partnerID=8YFLogxK

U2 - 10.1053/j.jrn.2010.06.024

DO - 10.1053/j.jrn.2010.06.024

M3 - Article

C2 - 21193322

AN - SCOPUS:79959238921

VL - 21

SP - 329

EP - 339

JO - Journal of Renal Nutrition

JF - Journal of Renal Nutrition

SN - 1051-2276

IS - 4

ER -